REQUEST A DEMO
Total
USD $0.00
Search more companies

Gsk Pharmaceutical Trading S.R.L. (Romania)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Gsk Pharmaceutical Trading S.R.L. Profile Updated: February 06, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Gsk Pharmaceutical Trading S.R.L. is based in Romania. The head office is in Bucharest. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. The enterprise was incorporated on August 27, 2020. Its’ total assets recorded a growth of 5.9%.

Headquarters
Soseaua Bucuresti-Ploiesti Nr. 89a
Bucharest; Bucharest;

Contact Details: Purchase the Gsk Pharmaceutical Trading S.R.L. report to view the information.

Basic Information
Registered Capital:
Purchase the Gsk Pharmaceutical Trading S.R.L. report to view the information.
Financial Auditors:
Purchase the Gsk Pharmaceutical Trading S.R.L. report to view the information.
Incorporation Date:
August 27, 2020
Key Executives
Purchase this report to view the information.
Administrator
Purchase this report to view the information.
Empowered representative
Ownership Details
Purchase this report to view the information.
65.0242%
Purchase this report to view the information.
34.7826%
Purchase this report to view the information.
0.0966%
Purchase this report to view the information.
0.0966%
Subsidiaries
Registrul Independent Monitor SA
3.33%
Company Performance
Financial values in the chart are available after Gsk Pharmaceutical Trading S.R.L. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Operating Profit
89.98%
EBITDA
89.98%
Net Profit/Loss for the Period
N/A
Total Assets
5.9%
Total Equity
6.63%
Return on Equity (ROE)
N/A
Quick Ratio
278.26%
Cash Ratio
269.67%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?